Lantern Pharma Inc. Property, Plant and Equipment
Lantern Pharma Inc. (LTRN) had Property, Plant and Equipment of $24.27 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:PropertyPlantAndEquipmentNet · last filed 2026-08-14
- 2026-06-30: Property, Plant and Equipment, Net $24.27K.
- 2026-03-31: Property, Plant and Equipment, Net $28.02K.
- 2025-12-31: Property, Plant and Equipment, Net $31.88K.
- 2025-09-30: Property, Plant and Equipment, Net $35.98K.
| Period end | Property, Plant and Equipment, Net |
|---|---|
| 2026-06-30 | $24.27K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $28.02K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $31.88K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $35.98K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $39.52K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $44.02K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $47.44K 10-K · filed 2026-03-30 |
| 2024-09-30 | $48.93K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $50.29K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $50.28K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $52.13K 10-K · filed 2025-03-27 |
| 2023-09-30 | $51.02K 10-Q · filed 2023-11-08 |
| 2023-06-30 | $49.95K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $53.47K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $48.01K 10-K · filed 2024-03-18 |
| 2022-09-30 | $43.81K 10-Q · filed 2022-11-07 |
| 2022-06-30 | $40.05K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $28.26K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $30.25K 10-K · filed 2023-03-20 |
| 2021-09-30 | $32.23K 10-Q · filed 2021-11-01 |
| 2021-06-30 | $30.60K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $20.16K 10-Q · filed 2021-05-03 |
| 2020-12-31 | $21.51K 10-K · filed 2022-03-10 |
| 2020-09-30 | $17.61K 10-Q · filed 2020-10-29 |
| 2020-06-30 | $15.38K 10-Q · filed 2020-07-30 |
| 2019-12-31 | $8.76K 10-K · filed 2021-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |